dallas semaglutide ileus law firm bowel obstruction legal team office semaglutide bowel obstruction law office in dallas Millions of patients dallas semaglutide constipation law firm in

Clients on GLP-1 protocols typically lose 10 to 20% or more of their body weight over 6 to 12 months of treatment

From 2022 to 2023 alone, spending on GLP-1 RAs increased by 62% in the United States

The first incretin-based drug specifically for weight loss was approved by the FDA in 2014 for adults with obesity or who were overweight with at least one weight-related condition

This peptide also boosts collagen production, essential for tissue repair, and reduces inflammation, which collectively accelerate healing (1, 6)

Long-term or indefinite use is common for sustained weight maintenance

If you want to lose weight, discuss your goals with your healthcare provider